PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Synthetic Immunology, Oncology and Immunology Section, Department of Surgery Oncology and Gastroenterology, University of Padua, Padua, Italy.\', \'Department of Transfusion Medicine, Padua University Hospital, Padua, Italy.\', \'Institute of Microbiology and Virology, Padua University Hospital, Padua, Italy.\', \'Department of Molecular Medicine, University of Padua, Padua, Italy.\', \'Oncology and Immunology Section, Department of Surgery Oncology and Gastroenterology, University of Padua, Padua, Italy.\', \'Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2022.830710
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35173741
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Neutralizing Antibody Responses to SARS-CoV-2 in Recovered COVID-19 Patients Are Variable and Correlate With Disease Severity and Receptor-Binding Domain Recognition.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all